These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 847537)

  • 21. Association between DR antigens, rheumatoid arthritis with and without extraarticular features and systemic lupus erythematosus in northern Italy.
    Ferraccioli G; Savi M
    J Rheumatol; 1988 Jan; 15(1):51-3. PubMed ID: 3258384
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hl-A antigens associated with rheumatoid arthritis and ankylosing spondylitis in an ethnic homogeneous population.
    Marcolongo R; Contu L
    Biomedicine; 1975 Apr; 23(3):88-91. PubMed ID: 1222227
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HLA antigens.
    Brewerton DA; Albert ED; Tiilikainen A
    Scand J Rheumatol Suppl; 1975; 12():139-40. PubMed ID: 1084560
    [No Abstract]   [Full Text] [Related]  

  • 24. HLA and disease manifestations in rheumatoid arthritis--a Canadian experience.
    Gladman DD; Anhorn KA
    J Rheumatol; 1986 Apr; 13(2):274-6. PubMed ID: 3459890
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HLA antigens and drug toxicity in rheumatoid arthritis.
    Ford PM
    J Rheumatol; 1984 Jun; 11(3):259-61. PubMed ID: 6610749
    [No Abstract]   [Full Text] [Related]  

  • 26. HLA antigens and toxic reactions to sodium aurothiomalate in patients with rheumatoid arthritis.
    Bensen WG; Moore N; Tugwell P; D'Souza M; Singal DP
    J Rheumatol; 1984 Jun; 11(3):358-61. PubMed ID: 6234391
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [HLA genomic tissue typing in myasthenic patients with rheumatoid arthritis].
    Varga E; Varga E; Jáger R; Petró A; Gyódi E; Bálint G; Náfrádi L; Varga L
    Orv Hetil; 2001 Oct; 142(41):2255-7. PubMed ID: 11760469
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Frequency of antigens of the HL-A system in rheumatoid arthritis and in ankylosing spondylitis in an ethnically homogeneous population].
    Marcolongo R; Contu L
    Reumatismo; 1975; 27(1):170-5. PubMed ID: 1233629
    [No Abstract]   [Full Text] [Related]  

  • 29. Seronegative rheumatoid arthritis: a clinical study with HLA typing.
    Kaarela K; Alekberova Z; Lehtinen K; Puolakka K; Koskimies S; Nassonova V; Pospelov L
    J Rheumatol; 1990 Sep; 17(9):1125-9. PubMed ID: 2290153
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HLA-A, B and DR antigens and properdin factor B allotypes in Caplan's syndrome.
    Darke C; Wagner MM; Nuki G; Dyer PA
    Br J Dis Chest; 1983 Jul; 77(3):235-42. PubMed ID: 6577907
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Histocompatibility antigens in rheumatic diseases].
    Schattenkirchner M; Schürer W; Diem K; Scholz S; Albert ED
    Verh Dtsch Ges Rheumatol; 1976; 4():368-72. PubMed ID: 997810
    [No Abstract]   [Full Text] [Related]  

  • 32. The major histocompatibility complex antigens in rheumatoid arthritis and juvenile arthritis.
    Miller ML; Glass DN
    Bull Rheum Dis; 1981; 31(5):21-5. PubMed ID: 6949623
    [No Abstract]   [Full Text] [Related]  

  • 33. HLA-DR, DQ and DP antigen expression in synovial fluid T lymphocytes in rheumatoid arthritis: cell cycle analysis of HLA-DP positive T cells.
    Hirose T; Goto M; Okumura K
    J Rheumatol; 1990 Jan; 17(1):18-23. PubMed ID: 1690301
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Incidence of HLA antigens in progressive seronegative arthritis].
    Svec V; Bosâk V; Nyulassy S; Zlnay D
    Fysiatr Revmatol Vestn; 1981 Apr; 59(2):86-90. PubMed ID: 7195377
    [No Abstract]   [Full Text] [Related]  

  • 35. Immunogenetics of familial rheumatoid arthritis: a study of 41 multicase families.
    Taneja V; Mehra NK; Singh RR; Anand C; Malaviya AN
    J Rheumatol; 1993 Feb; 20(2):253-8. PubMed ID: 8474060
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The HLA system and the rheumatic diseases.
    Marcelli-Barge A; Legrand L; Poirier JC; Schmid M; Dausset J
    Eur J Rheumatol Inflamm; 1982; 5(4):406-22. PubMed ID: 6983960
    [No Abstract]   [Full Text] [Related]  

  • 37. Toxicity due to remission inducing drugs in rheumatoid arthritis. Association with HLA-B35 and Cw4 antigens.
    Ferraccioli G; Peri F; Nervetti A; Ambanelli U; Savi M
    J Rheumatol; 1986 Feb; 13(1):65-8. PubMed ID: 3084782
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HLA class-I and class-II antigen association in rheumatoid arthritis at Varanasi, India.
    Agrawal V; Gupta RM; Usha ; Sharma SV
    Indian J Pathol Microbiol; 1996 Jan; 39(1):19-25. PubMed ID: 8755127
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HLA antigens in classical and malignant rheumatoid arthritis in Japanese population.
    Toyoda K; Saito S; Naito S; Konomi K; Yamamoto H
    Tissue Antigens; 1977 Jul; 10(1):56-9. PubMed ID: 70856
    [No Abstract]   [Full Text] [Related]  

  • 40. [B27 - DR4 arthritis and research on symptomatic effects of B27 antigens in rheumatoid polyarthritis and DR4 in ankylosing spondylarthritis].
    Chalès G; Coutard J; Pawlotsky Y; Bled B; Deramoudt B; Busson F; Fauchet R; Gueguen M
    Rev Rhum Mal Osteoartic; 1983 Nov; 50(11):777-81. PubMed ID: 6607503
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.